Your account is not claimed yet. You can sign up with ORCID to claim your account.

Natalie M Reizine (Natalie Reizine)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

JCO precision oncology

CA: a cancer journal for clinicians

Therapeutic advances in medical oncology

Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Natalie M Reizine, Samantha Socco, Eric Weng, Uka Atueyi, Vikas Mehta, Akash Patnaik
Utilization of Next-Generation Sequencing in Conjunction With Immunohistochemistry to Predict Exceptional Response to Combination Immune Checkpoint Therapy in a Heavily Pretreated Patient With Castration-Resistant Prostate Cancer. JCO precision oncology 7 (2023)
Natalie M Reizine, Peter H O'Donnell
Modern developments in germline pharmacogenomics for oncology prescribing. CA: a cancer journal for clinicians 72 (4) (2022)
Natalie M Reizine, Keith Danahey, Tien M Truong, David George, Larry K House, Theodore G Karrison, Xander M R van Wijk, Kiang-Teck J Yeo, Mark J Ratain, Peter H O'Donnell
Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing. Cancer 128 (8) (2022)
Natalie M Reizine, Keith Danahey, Emily Schierer, Ping Liu, Merisa Middlestadt, Jenna Ludwig, Tien M Truong, Xander M R Van Wijk, Kiang-Teck Jerry Yeo, Monica Malec, Mark J Ratain, Peter H O'Donnell
Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients. The oncologist 26 (11) (2021)
Natalie M Reizine, Everett E Vokes, Ping Liu, Tien M Truong, Rita Nanda, Gini F Fleming, Daniel V T Catenacci, Alexander T Pearson, Sandeep Parsad, Keith Danahey, Xander M R van Wijk, Kiang-Teck J Yeo, Mark J Ratain, Peter H O'Donnell
Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial. Therapeutic advances in medical oncology 12 (2020)
Natalie M Reizine, Bryan Peterson, Stephanie Moya, Yan Wang, Yi-Hung Carol Y H Tan, Oliver S Eng, Malcolm Bilimoria, Ernst Lengyel, Kiran Kalyan Turaga, Daniel V T Catenacci
Complete Response in a Patient With Chemorefractory EGFR-Amplified, PD-L1-Positive Metastatic Gastric Cancer Treated By Dual Anti-EGFR and Anti-PD-1 Monoclonal Antibody Therapy. JCO precision oncology 4 (2020)

Natalie M Reizine.css-eqlu8i{font-size:small;padding-left:4px;} (Natalie Reizine)

Publication Activity (10 Years)

Top Topics

Top Venues

Natalie M Reizine (Natalie Reizine)